Physician profile
Riaz Rahman
NPI 1518306596
$12,324.53
in general payments reported to CMS, 2019-2025
35 companies · $517 in 2025
The $517 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,982 · 2020: $2,090 · 2021: $1,740 · 2022: $1,218 · 2023: $1,878 · 2024: $900 · 2025: $517.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,295.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,105.41 | 2019-2022 | |
| Cardiovascular Systems INC. | $1,979.19 | 2019-2023 | Diamondback Coronary, Diamondback Peripheral |
| Edwards Lifesciences Corporation | $1,236.43 | 2019-2020 | |
| Shockwave Medical, INC | $862.34 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Medical L6 Intravascular Lithotripsy (Ivl) Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $700.27 | 2022-2025 | Impella |
| Esperion Therapeutics, INC. | $651.55 | 2020 | |
| Novartis Pharmaceuticals Corporation | $638.32 | 2021-2025 | |
| Abbott Laboratories | $553.89 | 2019-2024 | Diamondback Coronary, Ultreon, Diamondback Peripheral |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $479.68 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $364.29 | 2019-2022 | |
| Medtronic Vascular, INC. | $305.43 | 2019 | |
| Merck Sharp & Dohme LLC | $282.48 | 2022-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $193.03 | 2019-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $130.69 | 2020-2024 | Jardiance |
| Penumbra, INC. | $102.66 | 2022-2024 | Indigo System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $101.15 | 2020 | |
| Angiodynamics, INC. | $83.56 | 2020-2023 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $81.12 | 2022-2024 | Abre, Linq II |
| Amgen INC. | $67.76 | 2021-2024 | Repatha |
| Philips North America LLC | $58.53 | 2023 | |
| Pfizer INC. | $40.43 | 2022-2023 | |
| Atricure, INC. | $39.65 | 2023 | |
| Scpharmaceuticals INC. | $36.45 | 2025 | |
| Amarin Pharma, INC. | $34.54 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $23.75 | 2023 | Arcalyst |
| W. L. Gore & Associates, INC. | $22.92 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Cvrx, INC. | $20.10 | 2023 | Barostim Neo System |
| Chiesi USA, INC. | $19.96 | 2019 | |
| Xeris Pharmaceuticals, INC. | $19.72 | 2023 | Keveyis |
| Novo Nordisk INC | $17.95 | 2025 | Ozempic |
| Terumo Medical Corporation | $17.08 | 2025 | Tr Band |
| Tactile Systems Technology INC | $14.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.49 | 2022 | |
| Biofire Diagnostics, LLC | $13.04 | 2021 | |
| Biomerieux INC | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riaz Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.